Barcelona – – September 30, 2026 -- Fira de Barcelona will host the Tomorrow.Blue Economy World Congress (TBEWC) from November 3 to 5, bringing city ports, public administrations, research centres and startups together to develop strategies for the blue economy at the Gran Via venue.

Singapore – September 30, 2026 -- SWI Capital Holding Ltd. (Euronext Amsterdam: SWICH) reported €4.4 billion in total assets and €2.3 billion in Adjusted NAV for the six months ended June 30, 2026, a 53% increase from December 31, 2025, as the group accelerates its pivot from a diversified holding company into a global AI infrastructure and compute platform.

Stockholm – September 30, 2026 -- Autoliv, Inc. has retired 1,232,671 shares of common stock repurchased during the third quarter, reducing its total issued shares to 74,421,702 as of September 30, 2026.

Outstanding shares now stand at 72,006,695 following the retirement

Each outstanding share carries one vote. The retirement lowers the total count of issued shares, a mechanical adjustment tied to Autoliv's ongoing buyback program.

Oslo – September 30, 2026 -- Nel ASA's US subsidiary, Nel Hydrogen US, has secured approximately USD 7 million in new purchase orders from Collins Aerospace for PEM electrolyser stacks used in submarine life-support systems, pushing the company's total submarine-related order intake from Collins Aerospace to roughly USD 20 million this quarter.

Amsterdam – September 30, 2026 -- Edmund Zagorin, co-founder and Chief Strategy Officer at Arkestro, launched his first book, The Predictive Enterprise: How Superhuman Supply Chains Transform Global Business, at DPW Amsterdam on September 30, with a signing held at Arkestro's booth at 12:30 p.m. CEST.

London – – September 30, 2026 -- Tetragon Financial Group Limited has published its Monthly Factsheet for August 2026, providing shareholders with the latest disclosure on the Guernsey-based closed-ended investment company.

Berlin – – September 30, 2026 -- TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix® Newborn TREC/SMN1/HBB kit, an IVDR-approved in vitro diagnostic test that simultaneously screens newborns for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) in countries accepting the CE mark.

Washington – September 30, 2026 -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) reported positive topline results from a pivotal Phase III study of HETLIOZ® (tasimelteon) 20 mg in adults with Delayed Sleep-Wake Phase Disorder (DSWPD), setting up a supplemental New Drug Application (sNDA) filing with the U.S. Food and Drug Administration (FDA).

Indianapolis – September 30, 2026 -- Eli Lilly and Company (NYSE: LLY) reported that its investigational triple hormone receptor agonist retatrutide produced an average weight loss of 49.6 lbs (20.8%) over 80 weeks at the 12 mg dose in patients with type 2 diabetes and obesity, with more than half of participants no longer meeting BMI criteria for obesity. The Phase 3 TRIUMPH-2 results were presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan and simultaneously published in The Lancet.

Kista, Sweden – September 29, 2026 -- Sivers Semiconductors AB has called an Extraordinary General Meeting for 22 October 2026 to replace auditor Deloitte AB with Ernst & Young AB, a move tied to the company's plan for a dual listing on U.S. capital markets expected in the first half of 2027.